Showing 61 - 80 results of 1,096 for search '"drug resistance"', query time: 0.08s Refine Results
  1. 61
  2. 62

    Modeling and simulation of distribution and drug resistance of major pathogens in patients with respiratory system infections by Li Yang, Ermin Liang, Yali Gao

    Published 2025-01-01
    “…A mathematical model was developed to simulate the relationship between pathogen distribution and drug resistance. Results The most common pathogens were Streptococcus pneumoniae (30%), Haemophilus influenzae (20%), Pseudomonas aeruginosa (15%), Staphylococcus aureus (10%) and Klebsiella pneumoniae (10%). …”
    Get full text
    Article
  3. 63

    Design of a new class of broad-spectrum therapeutics targeted to drug-resistant bacteria by Amrutha Surendran, Agnes Turnbull, Allen Flockhart, Fern Findlay-Greene, Martyna Nowosielska, Donald Morrison, David J. Mincher, Samantha Donnellan

    Published 2024-12-01
    “…Key policy highlights Development of a novel class of antimicrobial compounds Drug screen against a WHO ‘high’ priority drug-resistant pathogen that poses the greatest threat to human health (methicillin-resistant Staphylococcus aureus) Drug screen against a surrogate for Mycobacterium tuberculosis, one of the leading causes of mortality worldwide.…”
    Get full text
    Article
  4. 64
  5. 65
  6. 66

    Pharmacological approaches in drug-resistant pediatric epilepsies caused by pathogenic variants in potassium channel genes by Ilaria Filareto, Ilaria Mosca, Elena Freri, Francesca Ragona, Laura Canafoglia, Roberta Solazzi, Barbara Castellotti, Giuliana Messina, Cinzia Gellera, Maria Virginia Soldovieri, Paolo Ambrosino, Maurizio Taglialatela, Jacopo C. DiFrancesco, Tiziana Granata

    Published 2025-01-01
    “…Variants in genes encoding for voltage-gated K+ (Kv) channels are frequent cause of drug-resistant pediatric epilepsies. Obtaining a molecular diagnosis gives the opportunity to assess the efficacy of pharmacological strategies based on in vitro features of mutant channels. …”
    Get full text
    Article
  7. 67
  8. 68

    Progress in programmatic management of drug-resistant TB, WHO Eastern Mediterranean Region, 2018-2023 by K. Bennani, M. van den Boom, M.G. ElMedrek, Y. Hutin

    Published 2024-09-01
    “…BACKGROUND: Since 2012, WHO has supported countries in scaling up programmatic management of drug-resistant tuberculosis (PMDT). We assessed progress and challenges to formulate recommendations for improvement. …”
    Get full text
    Article
  9. 69
  10. 70

    Lung abscess complicating ventilator-associated pneumonia caused by extensively drug-resistant Acinetobacter baumannii by Amit Kumar, Rajesh Chetiwal, Neha Rana, Aman Dubey, Shweta Tanwar

    Published 2025-01-01
    “…Ventilator-associated pneumonia (VAP) is a common and serious complication in critically ill patients, particularly those requiring prolonged mechanical ventilation. Extensively drug-resistant (XDR) Acinetobacter baumannii has emerged as a significant threat in VAP cases, complicating treatment due to its exceptionally high level of antibiotic resistance. …”
    Get full text
    Article
  11. 71
  12. 72

    Cost and cost-effectiveness of BPaL regimen used in drug-resistant TB treatment in the Philippines by D. Evans, K. Hirasen, D.J. Casalme, M.T. Gler, A. Gupta, S. Juneja

    Published 2024-06-01
    “…BACKGROUND: In 2022, the WHO announced that the 6-month BPaL/M regimen should be used for drug-resistant TB (DR-TB). We estimate the patient and provider costs of BPaL compared to current standard-of-care treatment in the Philippines.METHODS: Patients on BPaL under operational research, or 9–11-month standard short oral regimen (SSOR) and 18–21-month standard long oral regimen (SLOR) under programmatic conditions were interviewed using the WHO cross-sectional TB patient cost tool. …”
    Get full text
    Article
  13. 73
  14. 74

    Use of Innovative SPECT Techniques in the Presurgical Evaluation of Patients with Nonlesional Extratemporal Drug-Resistant Epilepsy by Ahmed Yassin, Khalid El-Salem, Abdel-Hameed Al-Mistarehi, Aiman Momani, Anas M. Zein Alaabdin, Palak Shah, James Michael Mountz, Anto I. Bagić

    Published 2021-01-01
    “…Up to 30% of patients with epilepsy may not respond to antiepileptic drugs. Patients with drug-resistant epilepsy (DRE) should undergo evaluation for seizure onset zone (SOZ) localization to consider surgical treatment. …”
    Get full text
    Article
  15. 75

    Primary HIV Drug Resistance among Recently Infected Cases of HIV in North-West India by C. K. Chauhan, P. V. M. Lakshmi, V. Sagar, A. Sharma, S. K. Arora, R. Kumar

    Published 2019-01-01
    “…Antiretroviral treatment may lead to the emergence of HIV drug resistance, which can be transmitted. HIV primary drug resistance (PDR) is of great public health concern because it has the potential to compromise the efficacy of antiretroviral therapy (ART) at the population level. …”
    Get full text
    Article
  16. 76
  17. 77

    Nitrofurantoin Drug Resistance Among Gram-Negative Bacteria Isolated from Urinary Tract Infections by Puranik VS, Balaraju T P, Pavitra T

    Published 2025-01-01
    “…Nitrofurantoin resistance was the highest in Acinetobacter sp.Conclusion Nitrofurantoin drug is commonly prescribed in uncomplicated UTIs and is frequently used in the treatment of multi drug resistant infections. It is very important to identify urinary tract pathogens up to species level. …”
    Get full text
    Article
  18. 78
  19. 79
  20. 80